Atopic Dermatitis Treatment with APG777

and APG990

Atopic Dermatitis Treatment with APG777

and APG990

Client:

Client:

Apogee Therapeutics logo

Client:

Client:

Apogee Therapeutics is a clinical-stage biotechnology company that discovers and develops novel therapies for a range of inflammatory and immunological diseases. The company seeks to achieve this by focusing on established biologic drivers of disease and applying advanced antibody engineering to create product candidates with optimized properties that may overcome the limitations of existing therapies.

Apogee Therapeutics is a clinical-stage biotechnology company that discovers and develops novel therapies for a range of inflammatory and immunological diseases. The company seeks to achieve this by focusing on established biologic drivers of disease and applying advanced antibody engineering to create product candidates with optimized properties that may overcome the limitations of existing therapies.

Apogee Therapeutics is a clinical-stage biotechnology company that discovers and develops novel therapies for a range of inflammatory and immunological diseases. The company seeks to achieve this by focusing on established biologic drivers of disease and applying advanced antibody engineering to create product candidates with optimized properties that may overcome the limitations of existing therapies.

Apogee Therapeutics is a clinical-stage biotechnology company that discovers and develops novel therapies for a range of inflammatory and immunological diseases. The company seeks to achieve this by focusing on established biologic drivers of disease and applying advanced antibody engineering to create product candidates with optimized properties that may overcome the limitations of existing therapies.

Project Goal

Project Goal

Project Goal

Project Goal

Apogee Therapeutics required a 3D animation to explain the mechanisms of action (MoA) of its monoclonal antibodies, zumilokibart (APG777) and APG990, for the treatment of atopic dermatitis. The animation demonstrated how zumilokibart blocks IL-13 to reduce type 2 inflammation and how APG990 targets the OX40 ligand to modulate the immune response. It also illustrated Apogee’s antibody recycling mechanism, which extends therapeutic half-life. Designed for investors and healthcare professionals, the animation simplified complex biological pathways and highlighted the benefits of Apogee’s treatments.

See full animation.

Apogee Therapeutics required a 3D animation to explain the mechanisms of action (MoA) of its monoclonal antibodies, zumilokibart (APG777) and APG990, for the treatment of atopic dermatitis. The animation demonstrated how zumilokibart blocks IL-13 to reduce type 2 inflammation and how APG990 targets the OX40 ligand to modulate the immune response. It also illustrated Apogee’s antibody recycling mechanism, which extends therapeutic half-life. Designed for investors and healthcare professionals, the animation simplified complex biological pathways and highlighted the benefits of Apogee’s treatments.

See full animation.

Apogee Therapeutics required a 3D animation to explain the mechanisms of action (MoA) of its monoclonal antibodies, zumilokibart (APG777) and APG990, for the treatment of atopic dermatitis. The animation demonstrated how zumilokibart blocks IL-13 to reduce type 2 inflammation and how APG990 targets the OX40 ligand to modulate the immune response. It also illustrated Apogee’s antibody recycling mechanism, which extends therapeutic half-life. Designed for investors and healthcare professionals, the animation simplified complex biological pathways and highlighted the benefits of Apogee’s treatments.

See full animation.

3D visualization of the Antibody molecules: zumilokibart (APG777) and APG990

Antibody molecules: zumilokibart (APG777) and APG990

Antibody molecules: zumilokibart (APG777) and APG990

Antibody molecules: zumilokibart (APG777) and APG990

APG777 internalized by cell

APG777 internalized by cell

APG777 internalized by cell

3D visualization of the atopic dermatitis lesions on the skin

Atopic Dermatitis

Atopic Dermatitis

Atopic Dermatitis

“Incredible animations that really help bring our science to life. I strongly recommend Visual Science!”

“Incredible animations that really help bring our science to life. I strongly recommend Visual Science!”

“Incredible animations that really help bring our science to life. I strongly recommend Visual Science!”

“Incredible animations that really help bring our science to life. I strongly recommend Visual Science!”

Patrick Hsu

Vice President, Medical Affairs

Vice President, Medical Affairs

Atopic dermatitis skin cross-section on a microscopic level - 3D visualizaiton

Epidermis and Dermis are impacted by Atopic dermatitis

Epidermis and Dermis are impacted by Atopic dermatitis

Epidermis and Dermis are impacted by Atopic dermatitis

Bacterial transposase dimer in complex with genomic DNA and bridge RNA

Zumilokibart binging to IL-13

Zumilokibart binging to IL-13

Zumilokibart binging to IL-13

IL-13 cytokine driving type 2 inflammatory signaling

IL-13 cytokine driving type 2 inflammatory signaling

IL-13 cytokine driving type 2 inflammatory signaling

The Process

The Process

Animation type:

Animation type:

3D Animation

3D Animation

Project timline:

Project timline:

7 weeks

Review:

Review:

3 zoom calls + 6 e-mail feedback sessions

3 zoom calls + 6 e-mail feedback sessions

Find out which of our 26 scientific animation options works best for investor relations and communications:

To bring Apogee Therapeutics’ research to life, we created a high-end 3D animation that visualized the complex molecular mechanisms underlying atopic dermatitis and its treatment with zumilokibart and APG990. Detailed 3D models illustrated skin barrier disruption caused by chronic inflammation, while dynamic molecular animations demonstrated how IL-13 and the OX40 ligand drive disease progression. Split-screen sequences were used throughout the animation to compare inflammatory pathways, treatment mechanisms, and therapeutic outcomes, providing a clear visual distinction between untreated and treated conditions. By leveraging cinematic 3D rendering and precise molecular interactions, we ensured the animation was both scientifically accurate and visually compelling.


High-End 3D Animation: Realistic molecular interactions and detailed skin models.


Molecular Visualization: Clear depiction of IL-13 and OX40 ligand signaling pathways.


Split Screens: Side-by-side comparisons of inflammation, treatment mechanisms, and outcomes.


Therapeutic Impact: Visualization of extended antibody half-life and reduced dosing frequency.

Why did we use this
animation type?

Why did we use this
animation type?

A high-end 3D animation was chosen to accurately depict the complex molecular interactions involved in atopic dermatitis and the treatments zumilokibart and APG990. Detailed 3D models of IL-13, OX40, and immune responses provided clarity while explaining intricate biological processes to both scientific and general audiences. The split-screen format enabled clear comparisons of the therapies’ mechanisms, highlighting their complementary roles in targeting type 1, type 2, and type 3 inflammation.

Outcome:

Outcome:

The final medical animation clearly conveyed the mechanisms of action of zumilokibart and APG990 in the treatment of atopic dermatitis. It simplified complex immune responses and showcased the therapies’ potential for long-lasting symptom relief with less frequent dosing. The animation successfully supported investor communications, educational outreach, and scientific presentations as part of broader medical communication services.

Full animation

Case Study Animation

Contact us

/10

“Fantastic team to partner with throughout the entire process. Excellent output and management!”

Pádraig Moran

Global Marketing Director, Pfizer

/10

"Visual Science produced an excellent website with incredible imagery, working in a professional, efficient manner to create a stunning final product! They were engaged through every step of the process and were attentive to the ideas we had in mind for our website. They continue to work with us on all updates and requests in a timely and helpful manner!"

Noel Kurdi

VP, Investor Relations, Apogee Therapeutics

/10

“Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”

Bob Nichols

VP, Corp Dev, Revolution Medicines

/10

“We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.

Rosana Kapeller

President, CEO and co-founder, ROME Therapeutics

/10

“Visual Science has a unique ability to communicate complex science with both accuracy and visual impact. Their team combines scientific understanding with creativity, helping bring sophisticated biomedical concepts to life.”

Paul Peter Tak

President, CEO and Board Director, Candel Therapeutics

/10

“We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”

Michael Zasloff

CSO, Enterin

/10

“I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”

Guru Reddy

Vice President, R&D, Unicycive Therapeutics

/10

"Visual Science was a great partner in the development and delivery of scientific animations; the combination of their understanding of the science and their artistic expertise resulted in a visually stunning and impactful video."

Lynnea Waters

Director, Scientific Communications, Apogee Therapeutics

/10

“Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”

Ravi Moorthy

VP, Head of Communications, Scorpion Therapeutics

/10

“Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”

John Hanna

CEO, Apton

/10

“We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”

Patrick Ritschel

CEO, Atsena Therapeutics

/10

“The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”

Blake Aronson

Program Manager, ACS

/10

“The creativity, scientific competency and professionalism of the Visual Science team not only enabled the generation of high-quality images, but also made it a pleasure to work with them.”

Jan Smith

CSO, Biology, Revolution Medicines

/10

"Incredible animations that really help bring our science to life. I strongly recommend Visual Science!"

Josh Cirulli

VP, Medical Affairs, Apogee Therapeutics

/10

“The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”

Anirvan Ghosh

CEO, UNITY Biotechnology

/10

"We were impressed with the Visual Science team's attention to detail and ability to extract key messages out of a complex scientific story. Their deep understanding of the science enabled them to turn our cryo-EM structures into a beautiful visual that shows the key aspects of the bridge recombination mechanism."

Patrick Hsu

Co-Founder, Arc Institute · Assistant Professor, UC Berkeley

/10

"The Visual Science team did an outstanding job delivering beautiful MOA videos for us. The animations and attention to detail were exceptional, and their flexibility throughout the process made a huge difference."

Jen Do, Associate Director, External Sci Comm, AbbVie

Jen Do

Associate Director, External Sci Comm, AbbVie

/10

"Excellent work by the Visual Science team!"

Miguel Sobral

Associate Director, BD&Strategy, Apogee Therapeutics

/10

"Excellent work and project management."

Daniel Martins, Scientific Director, AbbVie

Daniel Martins

Scientific Director, AbbVie

/10

"Visual Science produces high quality animations to support our unique science with agility and speed. I do value their partnership and look forward to working on more projects with them."

Aparna Shetty, Lead, Scientific Communications and Content, Astellas

Aparna Shetty

Lead, Scientific Communications and Content, Astellas

/10

"The VS team was outstanding to work with on this project. From the outset, the level of communication, organization, and attention to detail was exceptional. The VS team moved a complication MoA project forward on-schedule, with scientific rigor, and the result was a beautifully composed video that distilled complex biology in a visually accurate way. I highly recommend this team."

Taylor Schreiber, CEO, Shattuck Labs, Inc.

Taylor Schreiber

CEO, Shattuck Labs, Inc.

/10

"Thank you very much for such a great deliverable on a very tight timeline. I have been doing things like this for a long time and your incorporation of the Atsena insights to this with a very fast turnaround is very much appreciated and impressive."

Edmund Doherty - Vice President of Medical Affairs | Clinical Strategy | Global People Leader, Atsena Therapeutics

Edmund Doherty

Vice President of Medical Affairs, Atsena Therapeutics

/10

"Very responsive and efficient. Thank you!"

Brian Padden, Asset Strategy Leader, AbbVie

Brian Padden

Asset Strategy Leader, AbbVie

Contact us

/10

“Fantastic team to partner with throughout the entire process. Excellent output and management!”

Pádraig Moran

Global Marketing Director, Pfizer

/10

"Visual Science produced an excellent website with incredible imagery, working in a professional, efficient manner to create a stunning final product! They were engaged through every step of the process and were attentive to the ideas we had in mind for our website. They continue to work with us on all updates and requests in a timely and helpful manner!"

Noel Kurdi

VP, Investor Relations, Apogee Therapeutics

/10

“Excellent scientific partner and first class imagery. This team runs a tight ship and the process is clear. The tech and final product are first rate.”

Bob Nichols

VP, Corp Dev, Revolution Medicines

/10

“We were impressed by the Visual Science team’s ability to use exact protein structures to depict complex mechanisms in <90 seconds. The visuals are beautiful and tell a clear story.

Rosana Kapeller

President, CEO and co-founder, ROME Therapeutics

/10

“Visual Science has a unique ability to communicate complex science with both accuracy and visual impact. Their team combines scientific understanding with creativity, helping bring sophisticated biomedical concepts to life.”

Paul Peter Tak

President, CEO and Board Director, Candel Therapeutics

/10

“We were impressed by the scientific sophistication of the Visual Science team and their skill in capturing the concepts we wanted to communicate. The final video was exceptional.”

Michael Zasloff

CSO, Enterin

/10

“I was very impressed with scientific knowledge of the Visual Science team, which led to a fantastic visualization of the MOA of our drug. Attention to scientific details was extraordinary.”

Guru Reddy

Vice President, R&D, Unicycive Therapeutics

/10

"Visual Science was a great partner in the development and delivery of scientific animations; the combination of their understanding of the science and their artistic expertise resulted in a visually stunning and impactful video."

Lynnea Waters

Director, Scientific Communications, Apogee Therapeutics

/10

“Visual Science is a fantastic partner, capable of rendering the most complex science in compelling ways. They understood the science, and their production was excellent.”

Ravi Moorthy

VP, Head of Communications, Scorpion Therapeutics

/10

“Visual Science team has just the right blend of scientific acumen and digital animation expertise to pull off these challenging projects.”

John Hanna

CEO, Apton

/10

“We are very pleased with Visual Science — they are a very responsive group to work with and the final product is exactly what we had envisioned.”

Patrick Ritschel

CEO, Atsena Therapeutics

/10

“The scientific expertise really showed in the discussions and final products. Everybody was responsive and great to work with, and the animations were both engaging and accurate!”

Blake Aronson

Program Manager, ACS

/10

“The creativity, scientific competency and professionalism of the Visual Science team not only enabled the generation of high-quality images, but also made it a pleasure to work with them.”

Jan Smith

CSO, Biology, Revolution Medicines

/10

"Incredible animations that really help bring our science to life. I strongly recommend Visual Science!"

Josh Cirulli

VP, Medical Affairs, Apogee Therapeutics

/10

“The quality of the work from Visual Science was outstanding. They provide a bespoke service that was responsive to our requests and I would recommend them highly.”

Anirvan Ghosh

CEO, UNITY Biotechnology

/10

"We were impressed with the Visual Science team's attention to detail and ability to extract key messages out of a complex scientific story. Their deep understanding of the science enabled them to turn our cryo-EM structures into a beautiful visual that shows the key aspects of the bridge recombination mechanism."

Patrick Hsu

Co-Founder, Arc Institute · Assistant Professor, UC Berkeley

/10

"The Visual Science team did an outstanding job delivering beautiful MOA videos for us. The animations and attention to detail were exceptional, and their flexibility throughout the process made a huge difference."

Jen Do, Associate Director, External Sci Comm, AbbVie

Jen Do

Associate Director, External Sci Comm, AbbVie

/10

"Excellent work by the Visual Science team!"

Miguel Sobral

Associate Director, BD&Strategy, Apogee Therapeutics

/10

"Excellent work and project management."

Daniel Martins, Scientific Director, AbbVie

Daniel Martins

Scientific Director, AbbVie

/10

"Visual Science produces high quality animations to support our unique science with agility and speed. I do value their partnership and look forward to working on more projects with them."

Aparna Shetty, Lead, Scientific Communications and Content, Astellas

Aparna Shetty

Lead, Scientific Communications and Content, Astellas

/10

"The VS team was outstanding to work with on this project. From the outset, the level of communication, organization, and attention to detail was exceptional. The VS team moved a complication MoA project forward on-schedule, with scientific rigor, and the result was a beautifully composed video that distilled complex biology in a visually accurate way. I highly recommend this team."

Taylor Schreiber, CEO, Shattuck Labs, Inc.

Taylor Schreiber

CEO, Shattuck Labs, Inc.

/10

"Thank you very much for such a great deliverable on a very tight timeline. I have been doing things like this for a long time and your incorporation of the Atsena insights to this with a very fast turnaround is very much appreciated and impressive."

Edmund Doherty - Vice President of Medical Affairs | Clinical Strategy | Global People Leader, Atsena Therapeutics

Edmund Doherty

Vice President of Medical Affairs, Atsena Therapeutics

/10

"Very responsive and efficient. Thank you!"

Brian Padden, Asset Strategy Leader, AbbVie

Brian Padden

Asset Strategy Leader, AbbVie

Contact us

Contact us

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor,
New York, NY 10281, USA

Social networks

LinkedIn Logo
Vimeo Logo

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo

Visual Science is an award-winning medical animation and digital scientific communications company, trusted by leading biotech and pharmaceutical organizations since 2007, including J&J, Pfizer, Novartis, Roche, Takeda, Gilead, AbbVie, and 100+ others.

We specialize in science-grade MoA and MoD videos, medical animation, and scientific storytelling, as well as digital and AI-driven solutions for Medical Affairs, marketing, corporate communications, and investor relations.

Contacts

US toll-free

1 888 374-16-95

NY

1 516 340-37-30

Address

200 Vesey Street, 24th floor, New York, NY 10281, USA

© 2026, Visual Science. All rights reserved.

Privacy policy & Cookie policy

  • The Telly Awards logo
  • Hermes Creative Awards Logo
  • The Communicator Awards logo
  • National Science Foundation logo
  • Science Magazine Logo
  • Viddy Awards Logo
Visual Science Logo

Atopic Dermatitis Treatment with APG777

and APG990

Atopic Dermatitis Treatment with APG777

and APG990